Results 201 to 210 of about 232,533 (233)
Some of the next articles are maybe not open access.

Clostridium difficile Infection

Critical Reviews in Clinical Laboratory Sciences, 1996
The spore-forming anaerobe Clostridium difficile has become a serious enteropathogen. Changes in the composition of natural intestinal flora, mainly due to antibiotic therapy, permit its colonization of, and multiplication in, the colon. The disease is caused by (entero)toxin A and (cyto)toxin B, and infection ranges from asymptomatic carrier state and
Dieter H. M. Gröschel, B. Toye
openaire   +2 more sources

Update on Clostridium difficile

Current Treatment Options in Gastroenterology, 2006
The most dramatic change in the past several years has been the increased incidence and severity of Clostridium difficile colitis reported from multiple countries. A number of factors have likely contributed to this. One major event has been the emergence of a fluoroquinolone-resistant clone of C.
Cheleste M, Thorpe, Sherwood L, Gorbach
openaire   +2 more sources

Clostridium difficile

Disease-a-Month, 2009
Robin B, McFee, George G, Abdelsayed
openaire   +5 more sources

Clostridium difficile Toxinotyping

2010
Clostridium difficile shows considerable variability in the PaLoc region encoding two main virulence factors, toxins TcdA and TcdB. Strains with changes in PaLoc are defined as variant toxinotypes and currently 27 such groups are recognized (I to XXVII).
openaire   +2 more sources

Clostridium difficile toxin

Pharmacology & Therapeutics, 1981
T W, Chang, J G, Bartlett, N S, Taylor
openaire   +2 more sources

Clostridium-difficile-Infektion

DMW - Deutsche Medizinische Wochenschrift, 2010
Grünewald, T.   +4 more
openaire   +3 more sources

Epidemic Clostridium difficile

Medical Journal of Australia, 2006
openaire   +2 more sources

Clostridium difficile colitis: pathogenesis and host defence

Nature Reviews Microbiology, 2016
Eric Pamer   +2 more
exaly  

Clostridium difficile Colitis

American Journal of Gastroenterology, 1999
openaire   +2 more sources

Home - About - Disclaimer - Privacy